Top Health Tech Companies in Dublin (80)
InterSystems builds the software that makes complex systems work—reliably, securely, and at scale. For more than 45 years, we’ve been the information engine behind some of the world’s most mission-critical applications in healthcare, government, and business. Our data management, integration, and analytics technologies help organizations connect disparate systems, turn data into insight, and deliver better outcomes. From enabling interoperable healthcare and...
InterSystems's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Growth is described as measured and predictable, with signals such as modest headcount expansion, sustained operating scale, and continued momentum rather than volatility.
Innovation-Driven Growth: Recent major releases across IRIS/IRIS for Health/Health Connect and new AI-focused offerings indicate ongoing R&D velocity that broadens capabilities and use cases.
Strong Market Position & Advantage: Repeated industry accolades for Shared Care Records/HIE and regional acute EHRs in 2026 point to durable competitive standing in core healthcare markets.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Consolidated revenues increased from $253 billion in 2024 to $270.6 billion in 2025, with quarterly gains such as Q4 2025 up 8% year over year. Growth was led primarily by Optum Rx and supported by steady contributions from Optum Insight.
Market Expansion: Expansion through acquisitions such as Holston Medical Group (August 2025) and Alegeus (July 2026), alongside earlier combinations like Change Healthcare and Atrius Health, broadened capabilities across care, pharmacy, and payments. These moves extend Optum’s platform into adjacent services and operating domains.
Diversified Revenue Streams: A multi-segment model—Rx, Insight, and Health—helps sustain aggregate growth even as individual lines vary, with pharmacy and technology businesses offsetting care-delivery softness. Parent-company commentary continuing to frame Optum as a growth engine and raising 2026 guidance underscores the benefit of this portfolio effect.
VVater is a US-based, next-generation water treatment company that aims to provide Water for Humankind with a cornerstone of sustainability and a promise of a better, healthier tomorrow—servicing various industries and markets around the world from Real Estate, Wastewater Treatment, Municipal Potable Water, and multiple others, in particular, focusing on the recovering and recycling of different waters in a centralized...
ResMed provides medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
ResMed's Top Stability & Growth Strengths
Strong Market Position & Advantage: Industry and company materials indicate ResMed is the leading player in global sleep‑apnea devices and masks, supported by scale and a large connected ecosystem (AirView/myAir). Philips’ U.S. consent decree and extended remediation have provided a multi‑year window that reinforced ResMed’s relative momentum.
Strong Revenue Growth: Recent quarters show continued year‑over‑year revenue growth with margin expansion, driven by device demand and recurring masks/accessories. Management commentary and investor materials point to sustained momentum through FY2026 to date.
Diversified Revenue Streams: A large installed base of connected devices underpins recurring resupply revenue and remote monitoring workflows. Ownership of Brightree and MatrixCare adds out‑of‑hospital software that complements the core hardware franchise.
At Vertigenius™️, we're pioneering the integration of technology and healthcare to address vestibular disorders, improving balance and reducing dizziness. Our innovative approach includes a clinician portal, a patient app, and a wearable head sensor, making rehabilitation accessible and efficient.
Deciphex is focused on the development of software applications for preclinical/toxicologic pathology that improve productivity and help pathologists focus on the critical content.
The FoodMarble AIRE is the world's first personal digestive tracker. It helps people who experience digestive discomfort track how they respond to different foods. AIRE is a hand-held, affordable breath analysis device and associated app that is based on techniques used in gastroenterology departments around the world. The FoodMarble AIRE helps people optimize their diet for their unique digestive system....
4G Clinical is driven by a single purpose: bring crucial medicines to those who need them, faster. 4G Clinical believes that the way to accelerate clinical research is by disrupting the way trials are executed. That’s why we have revolutionized RTSM (randomization and trial supply management) and supply forecasting capabilities and services from the ground up.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power.
Bayer's Top Stability & Growth Strengths
Strong Market Position & Advantage: Bayer is positioned as a clear front-runner in Crop Science, with particularly strong standing when seeds/traits and digital agriculture are included alongside crop protection. It is also consistently placed within the top cohort globally in OTC/self-care, supporting leadership credibility across major end-markets.
Innovation-Driven Growth: Innovation activity is emphasized across seeds/traits, biologics, and digital farming, with multiple launches and late-stage programs cited as reinforcing Bayer’s pace-setting role in ag inputs. Newer pharmaceutical products like Nubeqa and Kerendia are described as ramping and helping offset headwinds from older brands.
Diversified Revenue Streams: The company operates across Crop Science, Pharmaceuticals, and Consumer Health, providing multiple earnings levers even when one segment faces cycle or lifecycle pressure. Incremental growth is highlighted as coming from Crop Science seeds/traits and newer Pharma assets while other categories remain flatter.
For over 240 years, Takeda’s propensity to evolve has driven the next generation of innovation, and as a future-focused organization, we’re continuing to drive forward with endurance in our steadfast pursuit to achieve the best outcomes for our patients in a rapidly changing world. We have been preparing for this period of value creation by investing in data, digital and...
Takeda's Top Stability & Growth Strengths
Strong Market Position & Advantage: Takeda is consistently placed among the global top 15–20 by revenue and is a clear category leader in GI/IBD, plasma-derived therapies, and dengue vaccines with broad international authorizations and WHO support. Subcutaneous ENTYVIO and new oncology approvals like FRUZAQLA broaden real‑world use and extend reach.
Profitability: Reported FY2025 operating profit rose 19.3% year over year and EPS nearly doubled despite a slight revenue decline, supported by lower amortization and restructuring expense. Core profitability remained broadly stable as Growth & Launch Products expanded their share.
Future-Ready Strategy: Management is investing through FY2026 to convert a late‑stage pipeline (e.g., oveporexton, rusfertide, zasocitinib) into multiple launches, with Growth & Launch Products prioritized as near‑term engines. A multi‑year transformation and efficiency program targeting significant savings by FY2028 is intended to fund launches and strengthen competitiveness.
The Wellola team believes only the sickest of the sick should be hospitalised and that the future of healthcare is preventative, community-based and supported by digital tools. Wellola prides itself in being highly user-focused, reliable, robust and easy-to-use. Our team have unique, in-depth sector know-how, our pricing model is extremely cost effective and our business model is scalable for national...
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for...
We at SiSú believe in ‘getting the good in’. Our vision is to improve the wellbeing of people everyday by offering our customers naturally great tasting healthy products. A small step in Nurturing a Healthier You. A trusted clean brand known for healthy nourishment and great taste
We save lives by ensuring that patients get the best test first. xRefer, our smart radiology referral platform, is now live
Affidea is a pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider, operating in Greece since 2005 to offer high-quality, integrated primary health services.
ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® boosts efficiency, ensures...
LetsGetChecked is a virtual care company that allows customers to manage their health from home, providing direct access to telehealth services, pharmacy, and laboratory tests with at-home sample collection kits for a wide range of health conditions including Sexual Health, Cholesterol, Diabetes, Thyroid, Coronavirus (COVID-19), and more. Founded in 2015, the company empowers people with the care they need to...
The Avoca Clinic is Ireland’s leading Plastic Surgery Clinic for a reason. Located in multiple discrete locations around the country, you’ll immediately feel the warmth and luxury of our beautifully designed spaces that are home to some of the most technologically advanced equipment and world-class surgeons. Offering the very latest procedures and techniques available to the cosmetic surgery industry, we...
Swiftqueue Enterprise Scheduling is like Air Traffic Control for Healthcare Appointments and Referrals. Our Patient First solutions deliver co-ordinated healthcare appointments and referral management in Ireland, UK & USA. We have helped our customer's significantly reduce the cost of clinic administration and deliver a demonstrable ROI. Our rapid deployment templates and integration APIs can deliver results for our customers in...
Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment. For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of...
Eli Lilly and Company's Top Stability & Growth Strengths
Strong Market Position & Advantage: By market value and category leadership in incretins, Lilly sits at or near the top of global pharma. Mounjaro/Zepbound are redefining obesity/diabetes, with Mounjaro becoming the world’s best‑selling prescription drug in early 2026.
Strong Revenue Growth: Results show outsized, volume-led acceleration, with Q1 2026 revenue reaching $19.8B. Management also raised 2026 sales guidance to about $82–$85B after very strong 2025 growth.
Innovation-Driven Growth: Recent approvals and pipeline progress beyond metabolic disease add new growth pillars. The FDA approval of Kisunla (donanemab) in 2024 and advancement of oral GLP‑1 programs broaden the portfolio.



.jpg)



















.png)




